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A strategy is presented that exploits the ability of synthetic polymers of different 
nature to disturb the strong self-assembly capabilities of amyloid based β-sheet 
forming peptides. Following a convergent approach, the peptides of interest were 
synthesised via solid-phase peptide synthesis (SPPS) and the polymers via 
reversible addition-fragmentation chain transfer (RAFT) polymerisation, followed by a 
copper(I) catalysed azide-alkyne cycloaddition (CuAAC) to generate the desired 
peptide-polymer conjugates. The particular interest lays in a modified version of the 
core sequence of the β-Amyloid peptide (Aβ), Aβ(16-20) (KLVFF). The influence of 
attaching short poly(N-isopropylacrylamide) and poly(hydroxyethylacrylate) to the 
peptides sequences on the self-assembly properties of the hybrid materials were 
studied via Infrared Spectroscopy, TEM and circular dichroism. The findings indicate 
that attaching these polymers disturb the strong self-assembly properties of the 
biomolecules to a certain degree and allow to influence the aggregation of the 
peptides based on their β-sheets forming abilities. This study presents an innovative 
route towards targeted and controlled assembly of amyloids like fibres to drive the 
formation of polymeric nanomaterials. 
 
Introduction 
Inspiration from nature and improved synthetic strategies have triggered dramatic 
advances in the development of multifunctional materials over the past two decades. 
The combination of biological materials such as proteins and peptides with synthetic 
polymers is of particular interest since the resultant conjugates benefit from the 
properties of both components.1 These hybrid materials have found many diverse 
applications, such as tissue engineering2, drug delivery3 and structured 
nanomaterials4. Nanomaterials in particular benefit greatly from the self-organisation 
properties of peptides, since they lead to hierarchical nanostructures of much higher 
complexity than those achievable with synthetic polymers.5 For instance, 
nanostructures such as nanofibres6 or nanotubes7 based on self-assembled 
polypeptides can be applied in regenerative medicine8 or nanoelectronics7. Various 
approaches to design peptide based nanomaterials, how to control and trigger their 
self-assembly has been described including their use to guide the formation of 
supramolecular structures and related functionalities.9, 10 The challenge has now 
shifted to the incorporation of additional functional molecules such as polymers for 
the generation of highly functional nanostructured materials.3, 11 The self-organisation 
properties of peptides or proteins can be used to encode structural information in the 
polymeric nanomaterials at the molecular level. In addition the synthetic polymer part 
of these nanomaterials can also affect the self-organisation properties of the peptides 
or proteins thus changing their reactivity. Peptides and proteins are well known to 
strongly self-assemble into β-sheets, which can further aggregate into ribbons and 
fibrils.12. Indeed, β-sheet forming peptides have been intensively discussed in the 
past decade in the context of protein misfolding diseases13, such as Alzheimer’s 
(AD)14  and Parkinson’s (PD) diseases15. In the case of AD, the β-Amyloid peptide 
(Aβ) is believed to aggregate into fibrils and form amyloids,16, 17 and several studies 
suggest that a critical sequence for fibrillisation is Aβ(16-20), KLVFF.5, 18 It has also 
recently been shown that addition of two more phenylalanine residues to that core 
sequence (FFKLVFF) permits even stronger aggregation via hydrophobic and 
aromatic interactions.19 Recent work has focused on attaching synthetic polymers to 
these β-sheets forming peptide sequences to investigate the influence on the β-sheet 
forming properties.4, 20 Synthetic strategies for peptide/protein-polymer conjugates 
are well described,3, 11, 21, 22 and the properties of the peptides polymer conjugates 
have been examined. Pochan et al. used ethylenglycol modified amino acids o 
synthesise poly’peptides’ which retain the α-helical structure of the amino acids.23 In 
some cases the self-assembly abilities of the conjugates and corresponding 
properties such as gel formation can be controlled by the degree of polymerisation 
and the balance between α-helical and β-sheet structures.24 Studies on the influence 
of conjugated synthetic polymeric chains to β-sheets forming peptides and their β-
sheets forming properties in particular have been reported as well.4, 25-28 For instance, 
Adams et al. have used polyethylene oxide (PEO) with side chain conjugated 
peptides to form vesicles,29 and Tzokova et al. have demonstrated the importance of 
the nature of the peptide and the relative balance between polymer and peptide for 
the self-assembly process.30 However there are limited precise investigation on the 
self-assembly properties of the resultant conjugates4, 27, 31-36 and there is still a high 
demand on understanding this process to exploit the self-assembly properties with 
full capacity. Poly(ethylene glycol) (PEG) is the most common polymer used in 
research on peptide-polymer conjugates aggregation because it improves 
biocompatibility and decreases immunoresponse.37 To date PEG is the only polymer 
considered in studies involving the core sequence of the β-Amyloid peptide (Aβ16-
20),20, 25, 31, 38, 39 and it has been reported that hydrophobically modified Aβ(16-20) 
sequences (FFKLVFF) form very strong self-assembled structures19 which are 
retained even after PEGylation25. These initial results suggest that the nature of the 
peptide may dictates the suitability of a given conjugate polymer to alter the strong 
self-assembly properties of the β-sheet forming peptides. Herein, we describe a 
systematic investigation on the capability of a polar polymer (poly(hydroxylethyl 
acrylate), PHEA) and a less polar polymer (poly(N-isopropyl acrylamide), PNIPAAM) 
to influence the self-assembly properties of a β-sheet forming peptide. A modified 
Aβ(16-20) sequence with two additional phenylalanine units (FFVLKFF) was used as 
a model system. In addition, Aβ(16-19) sequence, similarly modified with one 
phenylalanine units, (FVLKFF) was also investigated to assess the importance of 
phenylalanine in the peptide sequence. We opted for a convergent approach, in 
which the peptides and polymers were first synthesised via solid-phase peptide 
synthesis (SPPS) and reversible addition-fragmentation chain transfer (RAFT) 
polymerisation respectively, followed by a copper(I) catalysed azide-alkyne 
cycloaddition (CuAAC) to generate the desired peptide-polymer conjugates 
(Scheme 1).  
 Scheme 1:  a) Solid phase supported peptide synthesis of N3C4-FVLKFF-OH (1) and N3C4-FFVLKFF-OH (2); b) 
RAFT polymerisation to yield PNIPAAM20 (5) and PHEA20 (6) c) Microwave assisted CuAAC reaction to generate the 
FFVLKFF conjugates 8 (PNIPAAM20) and 10 (PHEA20) and the FVLKFF conjugates 7 (PNIPAAM20) and 9 (PHEA20). 
 
Materials and Methods 
Fmoc-Phe-OH, Fmoc-Lys(Boc)-OH, Fmoc-Leu-OH, Fmoc-Val-OH, 2-
(1Hbenzotriazole-1-yl)-1,1,3,3-tetramethyluronium (HBTU) were obtained from GL 
Biochem and used as supplied. Butyl-trithiocarbonate propanoicacid (BTCPA) was 
obtained from Dulux and used as supplied, and azoisobutyronitrile (AIBN) was 
obtained from Aldrich and precipitated from methanol prior to use. Hünig’s base N,N-
(Diisopropylethylamine, DIPEA), trifluoroacetic acid (TFA), Thioansiol, 
Triisopropylsilane, sulfurylchloride, and all solvents were ordered through Sigma-
Aldrich and used as received. N-isopropylacrylamide (NIPAaM) was purchased from 
Sigma-Aldrich and recrystallised before usage. Hydroxyethyl acrylate (HEA) was 
purchased from Sigma-Aldrich and was deinhibited before polymerisation. All other 
chemicals were ordered through Sigma-Aldrich and used without any further 
purification. 
Nuclear Magnetic Resonance (NMR). NMR analyses were carried out on Bruker 
Ultra Shield Avance Spectrometers (200 or 300 MHz). For all NMR analyses 
deuterated solvents as stated were used. 
Size Exclusion Chromatography (SEC).  SEC analyses were performed at 50°C 
using a Agilent SEC system (PL-GPC50 Plus), equipped with a guard column and 
two Polar Gel-M columns (300 x 7.5 mm) and a PL-RI detector. The system was 
running at 50°C with DMF using 0.1 wt% LiBr, 0.05g/L hydroquinone on a flowrate of 
0.7 mL/min. For sample analysis a poly-Styrene calibration has been used. 
Transmission Electron Micrsocopy (TEM). Samples were prepared by placing a 
drop of sample solution on a carbon coated copper grid covered with thin film of 
pioloform. Samples were air dried for at least 24 hours before the analysis. TEM 
images were obtained using a JOEL1400 electron microscope.  
Fourier Transform Infra-Red (FT-IR). FT-IR spectra were obtained from a Bruker 
ISF66v FT-IR from dried film of sample solution. The numbers of scans were set at 
32.  
Electrospray Ionisation Mass Spectroscopy. ESI analysis was performed using a 
Finnigan LCQ mass spectrometer. 
Circular Dichroism Spectroscopy (CD). CD spectra were recorded using a 
Chirascan spectropolarimeter (Applied Photophysics, UK).  Solutions of the peptides 
and conjugates in methanol were loaded in parallel plaque cells (Hellma quartz 
Suprasil®), with a 0.1 or 1 mm pathlength. The CD data were measured using 1 sec 
acquisition time per point and 0.5 nm step. The post-acquisition smoothing tool from 
Chirascan software was used to remove random noise elements from the averaged 
spectra. A residual plot was generated for each curve in order to verify whether or not 
the spectrum has been distorted during the smoothing process. The CD signal from 
the methanol was subtracted from the CD data of the peptide solutions. 
Small-Angle X-ray Scattering (SAXS). Experiments were performed on beamline 
ID02 at the ESRF, Grenoble, France. Samples, dissolved in methanol, were placed 
in a glass capillary mounted in a brass block for temperature control. Micropumping 
was used to minimise beam damage, by displacing a drop of the sample by 0.01-0.1 
mm for each exposure. The sample-to-detector distance was 1.2 m, and the x-ray 
energy was 12.46 keV. The q = 4 sin /  (2 is the scattering angle and  is the 
wavelength) range was calibrated using silver behenate. Data processing 
(background subtraction, radial averaging) was performed using the software 
SAXSUtilities. 
General procedure for the synthesis of peptides 1 and 2. 
The azide modified peptides N3C4-FVLKFF (1) and N3C4-FFVLKFFC4N3 (2) have 
been synthesized via standard solid-phase 9-fluorenylmethoxycarbonyl (Fmoc) 
peptide synthesis on a 2-chlorotrityl resin. 2 g (1.5 mmol g-1) 2-chlorotrityl resin was 
suspended in 5 mL DCM for 30 min. in a fritted syringe (10 mL). After the solvent has 
been filtered off, a solution of Fmoc-L-Phenylalanin-OH (6.0 mmol, 2.322 g) and N,N-
Diisopropylethylamine (DIPEA, Hünig’s Base) (12 mmol, 3.08 g) in DMF (5 mL) was 
added and shaken for 2 h. The solvent was filtered off and the resin was washed with 
DCM : MeOH : DIPEA 17 : 2 : 1 (3x10 mL) to cap any unreacted peptide chains. 
After washing the resin with DCM (3x10 mL), DMF (3x10 mL) and DCM (3x10 mL) it 
was dried in vacuum to be used for further SPPS. UV-Vis was used to determine a 
loading of 1.06 mmol Fmoc-L-Phenylalanin-OH per gramm resin. 0.5 g of the resin 
was used for further SPPS. For coupling of each Fmoc-protected L-amino acid, the 
resin was swollen in 5 mL DCM for 30 min. and deprotected with 20% solution 
piperidin in DMF (2x5 mL) for 3 min. After washing the resin with DMF (3x10 mL), 
DCM (3x10 mL) and DMF (3x10 mL) a solution of Fmoc-L-amino acid-OH (1.5 eq.), 
HBTU (2 eq.) to activate the N-terminus and DIPEA (5 eq.) in DMF (5 mL) was added 
and shacked over night (16 h). The solvent has been filtered off and the resin 
washed with DMF (5x10 mL) and unreacted chains capped with DCM : MeOH : 
DIPEA 17 : 2 : 1 (3x10 mL) for 2x3 min. After washing with DMF (5x10 mL) the next 
coupling step was performed. Upon addition of the last amino acid, the azide linker 
C4N3 3 which was synthesised according to previous work by our group (Hamilton 
ChemComm) was couple under the same reaction conditions. A mixture of TFA : 
Thioanisol : Triisopropylsilane : H2O = 88 : 5 : 2 : 5 (10 mL for 3 h) was used to 
isolate the desired peptide sequences 1 and 2 from the solid phase. The obtained 
solution was concentrated to near dryness, dissolved in a small amount of MeOH 
and precipitated from ice-cold Et2O. If necessary, preparative HPLC (ACN, H2O, 
TFA) was performed for purification. Drying in vacuum yielded the opaque solids 1 
and 2 (0.127 g, 41%). 
 
Analysis of 1: 
1H-NMR (d-TFA, 300MHz) δ = 7.223-7.393 (m, 15H, Har), 6.860 (s, br, NH, NH2), 
4.994-5.060 (d, 3H, 19.8 Hz, CHNHbackbone), 4.668-4.745 (d, J = 23.1Hz, 2H, 
CHNHbackbone), 4.467 (s, br, 1H, CHNHbackbone), 3.442 (s, br, 2H, CH2N3), 3.176-
3.324 (d, br, J = 44.4 Hz, 6H, CH2Phe), 2.597 (s, br, 2H, CH2NH2), 2.144-2.212 (m, 
3H, COCH2-, CH(CH3)2CH), 1.379-2.024 (m, br, 13H, CH2CH2N3, CH2CH2CH2N3, 
CH2CH2CH2NH2, CH2CH2NH2,  CH2(CH2)3NH2,  CH2(CH(CH3)2),  CH(CH3)2CH2), 
1.056-1.119 (m, br, 12H, CH3 peptide side chains) ppm.  
13C-NMR (d-TFA, 400MHz) δ = 178 (COOH), 177 (NHCO-), 175 (NHCO-), 136 (Car-
CH2), 131 (Car, Car-CH2), 129 (Car-CH2), 120 (Car), 118 (Car), 116 (Car), 113 (Car), 
19.5-62.5 (CH3, CH2, CH, 24C) ppm. MS (ESI
+) m/z = 925.25 (M+H+, 100). IR (ATR 
FT-IR) ν = 3282 (m, NH-H), 2153 (w, N3), 1679 (s, C=O, amide I), 1631 (m, C=O, 
amide I) cm-1. HighRes MS: found = 1072.59785 (M+H+), calculated = 1071.59. 
 
Analysis of 2: 
1H-NMR (d-TFA, 300MHz) δ = 7.143-7.280 (m, 20H, Har), 6.775 (s, br, NH, NH2), 
4.933-4.977 (d, J = 13.2 Hz, 4H, CHNHbackbone), 4.574-4.666 (d, J = 27.6 Hz, 2H, 
CHNHbackbone), 4.322 (s, br, 1H, CHNHbackbone), 3.077-3.359 (m, 10H, CH2N3, 
14, CH2Phe), 2.490 (s, br, 2H, CH2NH2), 1.441-1.837 (m, 16H, CH, CH2), 0.862-
1.031 (m, 12H, CH3 peptide side chains) ppm. 
13C-NMR (d-TFA, 300MHz) δ = 181.05 
(COOH), 178.54 (NHCO-), 176.12 (NHCO-), 175.43 (NHCO-), 175.12 (NHCO-), 
136.57 (Car-CH2), 131.20 (Car, Car-CH2), 129.92 (Car-CH2), 120.15 (Car), 118.62 
(Car), 115.07 (Car), 112.36 (Car), 18-62.27 (CH3, CH2, CH, 26C) ppm. MS (ESI
+) m/z 
= 1072.80 (M+H+, 100). IR (ATR FT-IR) ν = 3420 (m, NH-H), 2113 (w, N3), 1681 (s, 
C=O, amide I), 1629 (m, C=O, amide I) cm-1. HighRes MS: found = 925.52944 
(M+H+), calculated = 924.52. 
 
Synthesis of 5-azido pentanoic acid 3. 
The synthesis of the C4N3 linker is followed a procedure from Srinivasan
40 and 
Kakwere33. Under inert conditions, bromovaleric acid (40 mmol, 7.24 g) was 
dissolved in 8 mL MeOH and cooled down to 0oC. Thionylchloride (120 mmol, 14.27 
g) has be added dropwise under N2 atmosphere within 45 min. and stirred for 30 min. 
at 0oC. The reaction mixture was allowed to warm up to room temperature and was 
stirred for 19 h. After solvent evaporation, the residue was suspended in 50 mL 
ethylacetate and extracted with NaHCO3 (3 x 30 mL), H2O (3 x 30 mL) and brine (1 x 
30 mL). Drying over NaSO4 and removing the solvent under reduced pressure lead 
to a brown liquid.  
Upon addition of 30 mL DMSO, NaN3 (77 mmol, 5 g) was added under rapid stirring. 
This solution has been stirred at 50oC for 24 h and the resultant white suspension 
has been taken up with 20 mL H2O and was extracted with Et2O (4 x 40 mL). 
Washing with brine, drying over NaSO4 and removing the solvent under reduced 
pressure yield in a brown oil. After dissolving in 30 mL THF : H2O = 3 : 1 (v : v), 20 
mL aqueous LiOH (73 mmol) was added and the mixture was stirred for 4 h at room 
temperature. THF was removed under reduced pressure and the aqueous phase 
was combined with 50 mL ethylacetate. Washing with 1N HCl (3 x 50 mL), H2O (3 x 
50 mL) and brine (2 x 50 mL) and drying the combined organic phases over NaSO4 
and removing the solvent under reduced pressure yielded in 5 as brown oil (70.1%, 
4.01 g).  
1H-NMR (CDCl3, 300MHz) δ = 11.442 (s, 1H, OH), 3.233-3.276 (t, J=12.9MHz, 
6.6MHz, 2H, CH2N3), 2.328-2.375 (t, J=14.1MHz, 6.9MHz, 2H, CH2(CH2)3N3), 1.547-
1.726 (m, 4H, CH2CH2N3) ppm. 
1H-NMR data are in agreement with literature 
results.33 
 
Synthesis of (prop-2-ynyl propanoate)yl butyltrithiocarbonate (PPBTC, 4): 
The alkyne modified RAFT agent PPBTC 4 was synthesised as described by 
Konkolewicz et al.41 Butyltrithiocarbonate propanoic acid (BTCPA) (2.06 g, 8.60 
mmol) was dissolved in 50 mL DCM and cooled down to 0oC. Propargyl acohol (2.42 
g, 23.02 mmol), EDCI (3.02 g, 12.62 mmol) and DMAP (0.13 g, 1.1 mmol) was added 
and stirred at 0oC for 2 h. The reaction mixture was allowed to warm up to room 
temperature and was stirred for additional 16 h. Washing with H2O (5 x 20 mL), 
drying over MgSO4 and removing the solvents yielded to a yellow oil. Purification was 
achieved via passing over a silica pad using toluene : ethylacetate 9 : 1. Removing 
solvents and drying in vacuum gave the desired product 4 as yellow oil (91.7%, 2.16 
g). 1H-NMR (CDCl3, 300MHz) δ = 4.802-4.876 (q, J = 7.5Hz, 1H, SCHCH3CO), 4.726 
(t, J = 1.2 Hz, 2H, CH2CCH), 3.30-3.379 (t, J = 7.2 Hz, 2H, CH3(CH2)2CH2S-), 2.482-
2.498 (t, J = 2.4 Hz, 1H, CH2CCH), 1.595-1.725 (m, 5H, CH3CH2CH2CH2S-, 
SCHCH3CO), 1.385-1.484 (m, 2H, CH3CH2(CH2)2S-), 0.901-0.949 (t, J = 7.2 Hz, 3H, 
CH3(CH2)3S-). Data are in agreement with results previously reported by Konkolewicz 
et al.41 
 
General procedure for the synthesis of polymers. 
The RAFT agent 4 was prepared according previously reported by our group34, 41, 42. 
A mixture of monomer, removed from inhibitors, AIBN (AIBN : RAFT = 0.1 : 1 eq.) 
and solvents were added. The reaction vessel has been purged with N2 for 15 min. 
and left under a nitrogen atmosphere of 1atm for the polymerisation. N-
isopropylacrylamide polymerisation was performed in dioxane at 60oC, 
Hydroxyethayl acrylate in tert-butanol at 70oC and purified via precipitation from ice-
cold hexane : Et2O (4:1) or Et2O. The molecular weight of the polymers have been 
characterised by NMR and SEC. 
 Polymer [M]: [RAFT] Time / h Conversiona DPa Mn
b Đb 
5 PNIPAAM20 33 : 1 4 81 % 20 2540 5400 
6 PHEA20 33 : 1 3 88 23 2950 4600 
Table 1: Synthetic details and characterisation for polymers.a: Determined via 1H-NMR spectroscopy. b: 
Determined via SEC. SEC results uncorrected relative to PS standards. 
 
Analysis of 5: 
1H-NMR (d-TFA, 300MHz) δ =  4.805 (s, 2H, CH2, -O-CH2-CCH), 4.142 (s, 22H, CH, 
-NH-CH(CH3)2), 3.460 (s, 2H, CH2, CH3-(CH2)2-CH2-S-), 2.533, 2.378, 1.934, 1.769, 
1.290-1.406 (polymer backbone, CH3-CH2-CH2-CH2-S-, -O-CH2-CCH), 0.856-0.987 
(m, 5H, CH2, CH3-CH2-(CH2)2-S-, CH3, CH3-(CH2)3-S-) ppm.  
 
Analysis of 6: 
1H-NMR (d6-DMSO, 300MHz) δ = 4.769 (s, 23H, OH), 4.675 (s, 1H, -O-CH2-CCH), 
4.008 (s, 41H, -O-CH2-CH2-OH), 3.553 (s, 46H, -O-CH2-CH2-OH), 3.402 (s, 2H,  CH3-
(CH2)2-CH2-S-),  1.066-2.335 (m, polymer backbone, CH3-CH2-CH2-CH2-S-, CH3-
CH2-CH2-CH2-S-), 0.863-0.901 (t, 3H, CH3-(CH2)3-S-) ppm.  
 
General procedure for the synthesis of peptide-polymer conjugates 7, 8, 9, 10. 
The azide peptide sequences 1 and 2 were combined with the correspondent alkyne 
polymers 5 and 6, CuSO4*5H20, Sodiumascorbate and 5 mL DMF. After vortex 
mixing, the reaction was carried out in a microwave reactor at 100oC, 200W, for 15 
min. under continuous stirring and N2 cooling.  
 
 Molar equivalents mL 
 polymer  Azide peptide  CuSO4*5H2O Sodium 
ascorbate 
DMF 
7 PNIPAAM20 1.2 N3C4-FVLKFF 1 2 10 5 
8 PNIPAAM20 1.2 N3C4-FFVLKFF 1 2 10 5 
9 PHEA20 1.2 N3C4-FVLKFF 1 2 10 5 
10 PHEA20 1.2 N3C4-FFVLKFF 1 2 10 5 
Table 2: Microwave assisted Click reaction between azide peptide and alkyne polymers. 
All four peptide polymer conjugates were purified by a second microwave assisted 
click reaction at 80oC using an azide resin to remove any unreacted polymers. The 
azide resin was synthesised according to procedure previously used in this group.34  
Excess of copper was removed via filtration through neutral alumina. The solvent 
was evaporated under reduced pressure; the resultant brown residue was washed 
with H2O to remove any remains of sodiumascorbate. After centrifugation and drying 
in vacuum a brown solid could be isolated (64 mg, 43%). 
The conjugates have been characterised using 1H-NMR. The disappearance of the 
peak for the alkyne proton at and the methylgroup next to the triple bond indicated a 
complete reaction of the alkyne polymer In addition ESI-MS has been used but none 
of the starting materials were detected, meaning peptide and polymer have been 
completely consumed by the Click reaction. Furthermore the FT-IR spectra do not 
show any peaks correspondent to the azide, concluding that all azide has been 
completely reacted in the Click reaction. 
 
Analysis of 7. 
1H-NMR (d-TFA, 300MHz) δ = 8.587 (s, 1H, CCHtriazole), 7.257-7.395 (d, br, 15H, 
Har), 5.599 (s, 2H, OCH2Ctriazole), 4.758-5.095 (m, 10H, OH polymer, 
CHNHbackbone, NH), 0.974-4.502 (PNIPAAM backbone, RAFT side chain, Peptide 
side chains) ppm.  
 
Analysis of 8. 
1H-NMR (d-TFA, 300MHz) δ = 8.385 (s, 1H, CCHtriazole), 7.347 (s, br, 20H, Har), 
5.234 (s, 2H, OCH2Ctriazole), 1.045-4.993 (CHNHbackbone, PNIPAAM backbone, 
RAFT side chain, Peptide side chains) ppm.  
 
Analysis of 9. 
1H-NMR (d-TFA, 300MHz) δ = 8.902 (s, 1H, CCHtriazole), 7.646-7.778 (d, br, 15H, 
Har), 5.976 (s, 2H, OCH2Ctriazole), 1.046-5.203 (CHNHbackbone, PNIPAAM 
backbone, RAFT side chain, Peptide side chains) ppm. 
 
Analysis of 10. 
1H-NMR (d-TFA, 300MHz) δ = 8.614-8.690 (d, br, 1H, CCHtriazole), 7.341-7.486 (d, 
br, 20H, Har), 5.683 (s, 2H, OCH2Ctriazole), 0.501-5.131 (CHNHbackbone, 
PNIPAAM backbone, RAFT side chain, Peptide side chains) ppm.  
 
Results and Discussion 
The azide and alkyne functionalities were introduced in the peptide and polymer 
segment, respectively, following procedures previously published by our group.43 
Azide-modified FVLKFF (1) and FFVLKFF (2) were synthesised via solid-phase 
peptide synthesis (SPPS) and the azide group was introduced at the N terminal. The 
polymers were synthesised via reversible addition-fragmentation chain transfer 
(RAFT) polymerisation. The synthesis of the azide modified peptides 1 and 2 via 
SPPS leads to white solids in 41% yield (scheme 1a). Nuclear Magnetic Resonance 
Spectroscopy (NMR), Electro Spray Ionisiation Mass Spectrometry (ESI-MS), High 
Resolution Mass Spectrometry (High Res MS), Fourier Transformation Infrared 
Spectroscopy (FT-IR) (SI, fig. 1-4).Polymerisation of hydroxyethyl acrylate and N-
isopropyl acrylamide via reversible addition-fragmentation chain transfer (RAFT) 
polymerisation44-46 using chain transfer agent (CTA) 4 gave the functional polymers 
PHEA20 5 and PNIPAAM20 6 (scheme 1b) with low polydispersities of 1.1 and 1.2, 
respectively (SI, fig. 5) and were verified via 1H (NMR) (SI, fig. 6). The desired 
peptide-polymer conjugates 7, 8, 9 and 10 were synthesised via a convergent 
approach42, 47 using microwave assisted copper-catalysed azide-alkyne cycloaddition 
(CuAAC) (scheme 1c). Successful cycloaddition reaction  was confirmed via 1H NMR 
(fig. 1a; SI, fig. 7-8), FTIR (fig. 1b) and SEC (SI, fig. 9).  
 Figure 11: a) 1H NMR spectrum of PNIPAAM20-FVLKFF conjugate 7 confirming the successful click reaction. b) 
FT-IR spectrum from dried films of 1wt% methanol solutions of PHEA20-FFVLKFF conjugate 10, showing the 
disappearance of the azide peak at 2153 cm
-1
 (black box) as a result of the successful click reaction. 
The 1H NMR spectrum (fig. 1a) of PNIPAAM20-FVLKFF conjugate 7 reveals the 
characteristic peak for the proton (H13’) at the newly triazole ring formed during the 
CuAAC at 8.587 ppm. The proton next to the ester functionality (H12) has been 
shifted down field from 4.805 ppm to 5.590 ppm (H12’) which confirms the successful 
coupling reaction. The disappearance of the azide band at 2153 cm-1 in the FT-IR 
spectrum (fig. 1b) of PHEA20-FFVLKFF conjugate 10 verifies a successful conjugate 
formation. A shift of the SEC traces for PNIPAAM20 and PHEA20 indicates the 
successful coupling between the azide and alkyne. The SEC traces of the PNIPAAM 
conjugates 7 and 8 (SI, fig. 9) are shifted towards a longer retention time which 
indicates a higher hydrodynamic volume compared to the pure PNIPAAM20. For both 
PHEA20 conjugates 9 and 10 the SEC traces are shifted to shorter retention times 
due to a lower hydrodynamic volume of the conjugates compared to the pure PHEA20 
(SI, fig. 9b). 
 
Self-assembly studies 
The self-assembly properties of peptides 1 and 2 and of the correspondent 
PNIPAAM20 and PHEA20 conjugates 7, 8, 9 and 10 have been studied in 1wt% 
methanol solutions or as the related dried films of 1wt% or 5wt% methanol solutions. 
FT-IR spectroscopy of dried films (1 wt % solutions in methanol) of 1 and 2 all show 
the characteristic bands for β-sheet assemblies at around 1631 cm-1 (parallel β-
sheets) and 1679 cm-1 (antiparallel β-sheets)48 indicating that the additional azide C4-
linker does not disturb the ability to form β-sheet assemblies (fig. 2a). Circular 
dichroism (CD) spectra of peptides 1 and 2 also reveal characteristic β-sheet 
features49. A negative band around 230 nm and a positive band at 218 nm is 
observed for 1 and a negative band at 230 nm and a positive band at 220 nm for 2 
(fig. 2b).  
 
Figure 2: a) FT-IR spectrum of amino peptides and correspondent azide modified peptides 1 and 2 displaying the 
characteristic bands for β-sheets around 1679 cm
-1
 and 1631 cm
-1
. B) Circular dichroism spectrum of azide peptides 
1 and 2 showing the characteristic negative and positive bands for β-sheet structures. 
The classical β-sheet circular dichroism spectrum has a minimum at 216-220 nm.5, 50 
The red-shift for this minimum to 230 nm and 235 nm respectively is due to the 
formation of J-aggregates from a head-to-tail stacking of the aromatic units51 and is a 
known feature for fibre formation49. These findings imply the presence of β-sheet 
structures in both azide peptides 1 and 2. A strong band at 225 nm observed for 2, 
which results from the fourth phenylalanine residue, shows the influence of these 
additional π-π stacking on the secondary structure of the peptide. Measurements 
using different concentrations display a concentration dependency of the formation of 
β-sheet structures. At low concentration (0.16 wt%) only a weak band around 230 nm 
could be observed, but upon increasing the concentration to 0.63 wt% and 0.9 wt% 
clear features for β-sheet structures could be obtained (SI, fig. 10). That confirms that 
the addition of the azide linker does not distroy the β-sheet forming abilities. 
TEM and SEM images were obtained from dried films of 1wt % methanol solutions 
on carbon coated copper TEM grids. One of the advantages of applying CuAAC to 
generate the desired conjugates is no additional staining of the TEM samples is 
required.42 The azide peptides 1 and 2 clearly show strong entangled networks 
(fig. 3) which points out the strong ability of 1 and 2 to not only form β-sheet 
assemblies, as supported by FT-IR and CD data, but also to aggregate in larger 
structures. 
 Figure 3: Typical TEM images of aggregates obtained from self-assembly of the conjugates (dried films of 1wt% 
methanol solutions): a) TEM image of N3C4-FVLKFF-OH 1; b) TEM image of N3C4-FFVLKFF-OH 2; c) SEM image of 
N3C4-FFVLKFF-OH 2. 
The aggregation properties of the conjugates were investigated by FT-IR, CD, TEM 
and SAXS. FT-IR spectra show that FFVLKFF conjugates 8 (PNIPAAM20) and 10 
(PHEA20) and FVLKFF conjugates 7 (PNIPAAM20) and 9 (PHEA20) are still able to 
form β-sheet assemblies (fig. 4). The FT-IR spectrum of FVLKFF PNIPAAM20 
conjugates 7 displays a slight shoulder at 1691cm-1 (fig. 4a, black arrow) which 
implies the presence of antiparallel β-sheets. The correspondent band around 1630 
cm-1 from the parallel β-sheets is covered under the broad band from the PNIPAAM 
residue at 1652 cm-1. We conclude the broadness of the band for conjugate 7 around 
1652 cm-1 and the appearance of the shoulder at 1691 cm-1 is evidence for to the 
presence of β-sheet structures which overlaps with the C=O stretching band of the 
PNIPAAM part of the molecule. The FT-IR spectrum of the FVLKFF-PHEA20 
conjugate 9 (fig. 4b) shows a strong band around 1733 cm-1 resulting from the C=O 
stretching band from the ester group of the PHEA side chain. At 1637 cm-1 and 1685 
cm-1 appear two bands which are assigned to β-sheet structures (β-sheet and 
antiparallel β-sheet respectively). From these results we assume that the attachment 
of PHEA20 does prevent the formation of strong fibre like networks but β-sheets are 
still formed. For FFVLKFF PNIPAAM20 conjugates 8 two bands at 1550 cm
-1 and 
1652 cm-1 (fig. 4c) were observed resulting from the PNIPAAM residue. No shoulder 
around 1691cm-1 could be obtained. But the broadness of the band at 1652 cm-1 for 8 
is much more pronounced than the band for the pure PNIPAAM (fig. 4c, indicated 
with arrows). We conclude that the C=O stretching band from PNIPAAM overlay the 
bands from parallel and antiparallel β-sheets. Further proof for the existence of β-
sheet structures will be discussed below. The FT-IR spectrum of the FFKLVFF-
PHEA20 conjugate 10 shows also strong band around 1733 cm
-1 from the ester group 
of the PHEA side chain. In addition a band 1687 cm-1 and 1644 cm-1 are obtained 
(fig. 4d, marked with arrows), which are assigned to antiparallel and respectively 
parallel β-sheets. 
 Figure 4: FT-IR spectra of conjugates 7 (a), 9 (b), 8 (c) and 10 (d) of dried films of 1wt% methanol solutions. 
Arrows indicate the relevant bands or changes in band shapes. 
 
In order to investigate whether the FT-IR features are due to the conjugate 7, 8, 9 
and 10 FT-IR mixing experiments were performed using peptide 1 and 2 and  
PNIPAAM20 and PHEA20 in a 1:1 mixture (SI, fig. 11 and fig. 12). For all four 
conjugates a clear red-shift of the amide bands is obtained, which is indicative of the 
formation of sheet-like aggregates. Moreover the mixture of FVLKFF 1 and 
PNIPAAM20 5 displays a distinct shoulder in the related amide band around 
1650 cm-1 indicating the presence of two different species in the solution with 
overlapping FT-IR bands. The FT-IR spectrum of the mixing experiment with 
FFVLKFF 2  and PNIPAAM20 5 in a 1:1 mixture (SI, fig. 11b) shows a splitting of the 
band at 1652 cm-1 which is associated with the presence of two discrete compounds.  
SAXS measurements on the FFVLKFF conjugates 8 (PNIPAAM20) and 10 (PHEA20) 
and on the FVLKFF conjugates 7 (PNIPAAM20) and  9 (PHEA20) in methanol (1wt%) 
do not show any aggregation for conjugates 7, 8, 9 and 10 under the conditions 
modelled by SAXS (fig. 5). In fact the SAXS data for conjugatesthe FFVLKFF 
conjugates 8 (PNIPAAM20) and 10 (PHEA20) can be modelled as Gaussian coil 
structures with a radius of gyration 2-2.5 nm, which is reasonable considering the 
polymer chain dimensions. thus no aggregation occurs under the SAXS conditions. 
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In addition no aggregation of the FVLKFFFor the FVLKFF conjugate conjugate 7 
could be detected. However SAXS experiments for FVLKVV-PHEA20 9, it was also 
possible to fit the data to a Gaussian coil model. However, the obtained radius of 
gyration (4.4 nm) is larger than for the FFVLKFF conjugates. Gaussian coil form 
factor fitting was less successful for the SAXS data for conjugate 7 since the SAXS 
intensity exhibits an extended range (including low q) with a q-2 dependence. This 
indicates aggregation, consistent with the TEM images, and this intensity scaling is in 
fact expected for a sheet-like structure. Therefore, the SAXS data for conjugate 7 
was fitted to a model of a homogeneous sheet (i.e. a planar object with extended 
lateral dimensions but finite thickness and a uniform electron density) of thickness 1 
nm (30% thickness polydispersity) confirm the presence of aggregates which are 
modelled as sheet-like aggregates due to an observed q-2 regime of intensity decay. 
The model of sheet-like structures is consistent with the TEM images, and data on 
related FFKLVFF-PEG conjugates.52 Fig. 5 shows representative profiles. For 9, form 
factor fitting was possible using a model of a homogeneous sheet of thickness 1 nm 
(30% thickness polydispersity) and this model describes the intensity profile very 
well. 
 
Figure 5: SAXS data for conjugates 7, 8, 9 and 10 (1 wt% in methanol) The solid line through the data for 
conjugate 8 and 10  is the model form factor fit for the Gaussian coil structure described in the text. 
 
Circular dichroism spectra were obtained from 1wt% solutions of the conjugates in 
methanol. The CD spectra of PNIPAAM20 conjugates 7 and 8 and PHEA20 conjugates 
9 and 10 (fig. 6b and 6c) in methanol display bands for β-sheet assemblies and 
confirm the FT-IR results. PNIPAAM20 conjugates 7 and 8 display a negative 
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maximum at 235 nm and a positive maximum at 220 nm (fig. 6a). The corresponding 
PHEA20 conjugate 9 displays a minimum at 235 nm and a dominating maximum at 
225 nm, confirming the presence of β-sheets and aromatic stacking (fig. 6b). For 
conjugate 10 a broad minimum around 215-230 nm is observed as a result of a 
strong β-sheet component and a small band at 225 nm for the ππ-stacking from the 
aromatic residues (fig. 6b). The observed red-shift of the minimum around 218 nm to 
230 nm in all four spectra are induced by strong maximum from the n-π* aromatic 
interactions.53 
 
Figure 6: a) Circular dichroism spectrum of azide peptides 1 and 2 showing the characteristic negative and 
positive bands for β-sheet structures (1wt% methanol); b) Circuar Dichroism spectrum of PNIPAAM20 conjugates 7 
and 8 (1wt% methanol); c) Circuar Dichroism spectrum of PHEA20 conjugates 9 and 10 (1wt% methanol). 
 
The CD spectra also support the conclusion by SAXS experiments that the peptide 
aggregation is disturbed by PNIPAAM20. Indeed, FVLKFF conjugate 7 shows a red 
shift of the negative band from 230 nm to 235 nm which indicates a coiled structure 
for the PNIPAAM conjugate (fig. 7a).49  
 
Figure 7: a) Circular Dichroism spectrum of FVLKFF 1 and correspondent PNIPAAM20 and PHEA20 conjugates 7 
and 9 from 1wt% methanol solution; b) Circular Dichroism spectrum of FFVLKFF 2 and correspondent PNIPAAM20 
and PHEA20 conjugates 8 and 10 from 1wt% methanol solution. 
 
The CD spectrum of FFVLKFF conjugate 8 shows similar bands to the unconjugated 
peptide, indicating that the additional fourth phenylalanine residue strengthen the 
self-assembled structure, despite the presence of PNIPAAM. CD spectra of the 
PHEA conjugates 9 and 10, (fig. 7a and 7b) show typical β-sheet bands with a 
maximum at 195 nm and a minimum at 218 nm. We rationalise these observations 
by the ability of the polymer chain to alter the aggregation of the peptide segment 
depending on the nature of the polymer conjugate. PNIPAAM chains interact with the 
peptide segment, possibly as it is less favoured by the solvent (methanol) and / or via 
H-bond formation between the amide groups found in the peptide and the acrylamide 
repeating units. Such interactions do not completely prevent β-sheet assemblies, but 
strongly disturb aggregation in larger structures. The introduction of a fourth 
phenylalanine residue in the peptide segment strengthens the peptide assemblies 
and allows for the formation of larger aggregates, despite the presence of the 
PNIPAAM chain. The more polar PHEA chains have greater interactions with the 
solvent, and do not affect to the same extent β-sheet formation. The PHEA conjugate 
only partially prevents aggregation and favour dispersion in the solvent, thus leading 
to the formation of smaller structures. We have previously observed that conjugating 
PHEA to the β-sheet forming peptide P11-2 prevents the assembly of the peptidic 
segment.33 This highlights the much stronger tendency of peptides 1 and 2 compared 
to peptide P11-2 to aggregate into β-sheet-like structures and the importance of the 
functionality of the polymer to interfere with the peptide fibrillization.  
TEM images of all four conjugates (fig. 8) reveal a small number of large aggregates, 
and confirm that attaching the polymers to peptide 1 and 2, although not extensively 
disturbing β-sheet formation, prevents the formation of strongly entangled networks. 
 
Figure 8: Typical TEM images of aggregates obtained from self-assembly of the conjugates (dried films of 1wt% 
methanol solutions): a) FVLKFF PNIPAAM20, b) FFVLKFF PNIPAAM20, c) FVLKFF PHEA20 and d) FFVLKFF PHEA20 
conjugates. Magnification is displayed on the top right corner of each image.  
 
TEM also confirmed that the self-assembly process of the conjugates into sheet-like 
aggregates is time and concentration dependent, an observation also made by CD 
spectroscopy. 
 
Figure 9: TEM images of self-assembled aggregates (dried films of 1wt% methanol solution). a) freshly prepared 
PHEA20-FVLKFF-OH 9 (1 wt%); b) incubated PHEA20-FVLKFF-OH 9 (1 wt%); c) incubated PHEA20-FVLKFF-OH 9 (5 
wt%); incubated PHEA20-FFVLKFF-OH 10 (5 wt%) 
Indeed, TEM images from freshly prepared conjugate solutions (1 wt% in methanol) 
show only small and thin aggregates (fig. 9a; SI, fig. 13-14, left). However, allowing 
the aggregates to self-assemble for 66 hrs lead to an increased length (~50-200 nm) 
and diameter (~10-20 nm) in the range expected for amyloidal structures53 (fig. 9b; 
SI, fig. 13-14, right) indicating that the peptide part of the conjugate still has an 
impact on the overall properties of the conjugate and that the peptide properties 
become more pronounced after a period of time. However even after 66 hrs of 
incubation of the self-assembly process the entanglement of the aggregates are 
much less compared to the peptides 1 and 2 it selves. Increasing the concentration 
from 1 wt% to 5 wt% in PHEA20 conjugates 9 (fig. 9c) and 10 (fig. 9d) led to the 
formation of larger and more structured aggregates. This gives the opportunity to 
influence the formation of the aggregates. 
 
Conclusion 
In conclusion, we have described a synthetic strategy and self-assembly studies for 
novel peptide-polymer conjugates, utilizing the manipulation of the self-assembly 
process via modified sequences from the β-amyloid peptide. Attaching short 
polymers of different functionality, PNIPAAM20 and PHEA20, to these peptide 
sequences disturbs their strong fibrillisation properties and offers some degree of 
control over their aggregation. Our findings point out that a sensible choice in the 
nature of polymer conjugate in relation to the solvent may allow control over the self-
assembly process. This approach is a promising way to address the challenging task 
to control the strong aggregation of β-sheet forming peptides and their use for 
controlled synthesis of functionalised supramolecular polymeric structures.   
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